Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 408

1.

Flavopiridol's effects on metastasis in KRAS mutant lung adenocarcinoma cells.

Dogan Turacli I, Demirtas Korkmaz F, Candar T, Ekmekci A.

J Cell Biochem. 2018 Oct 14. doi: 10.1002/jcb.27846. [Epub ahead of print]

PMID:
30317654
2.

Bergenin: a computationally proven promising scaffold for novel galectin-3 inhibitors.

Jayakody RS, Wijewardhane P, Herath C, Perera S.

J Mol Model. 2018 Oct 2;24(10):302. doi: 10.1007/s00894-018-3831-4.

PMID:
30276553
3.

The clinical importance of serum galectin-3 levels in breast cancer patients with and without metastasis.

Topcu TO, Kavgaci H, Gunaldi M, Kocoglu H, Akyol M, Mentese A, Yaman SO, Orem A, Ozdemir F, Aydin F.

J Cancer Res Ther. 2018 Sep;14(Supplement):S583-S586. doi: 10.4103/0973-1482.176425.

4.

Galectin-3 promotes CXCR2 to augment the stem-like property of renal cell carcinoma.

Huang CS, Tang SJ, Lee MH, Chang Wang CC, Sun GH, Sun KH.

J Cell Mol Med. 2018 Sep 24. doi: 10.1111/jcmm.13860. [Epub ahead of print]

5.

Temporal and molecular dynamics of human metastatic breast carcinoma cell adhesive interactions with human bone marrow endothelium analyzed by single-cell force spectroscopy.

Xie L, Sun Z, Hong Z, Brown NJ, Glinskii OV, Rittenhouse-Olson K, Meininger GA, Glinsky VV.

PLoS One. 2018 Sep 20;13(9):e0204418. doi: 10.1371/journal.pone.0204418. eCollection 2018.

6.

Endogenous and exogenous galectin-3 promote the adhesion of tumor cells with low expression of MUC1 to HUVECs through upregulation of N-cadherin and CD44.

Cao Z, Hao Z, Xin M, Yu L, Wang L, Zhang Y, Zhang X, Guo X.

Lab Invest. 2018 Aug 31. doi: 10.1038/s41374-018-0119-3. [Epub ahead of print]

PMID:
30171204
7.

Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas.

Wehrhan F, Büttner-Herold M, Distel L, Ries J, Moebius P, Preidl R, Geppert CI, Neukam FW, Kesting M, Weber M.

BMC Cancer. 2018 Aug 16;18(1):823. doi: 10.1186/s12885-018-4726-6.

8.

Synephrine Hydrochloride Suppresses Esophageal Cancer Tumor Growth and Metastatic Potential through Inhibition of Galectin-3-AKT/ERK Signaling.

Xu WW, Zheng CC, Huang YN, Chen WY, Yang QS, Ren JY, Wang YM, He QY, Liao HX, Li B.

J Agric Food Chem. 2018 Sep 5;66(35):9248-9258. doi: 10.1021/acs.jafc.8b04020. Epub 2018 Aug 27.

PMID:
30113849
9.

Molecular Recognition of a Thomsen-Friedenreich Antigen Mimetic Targeting Human Galectin-3.

Santarsia S, Grosso AS, Trovão F, Jiménez-Barbero J, Carvalho AL, Nativi C, Marcelo F.

ChemMedChem. 2018 Oct 8;13(19):2030-2036. doi: 10.1002/cmdc.201800525. Epub 2018 Sep 11.

PMID:
30094951
10.

Pulmonary metastatic colonisation and granulomas in NOX2-deficient mice.

van der Weyden L, Speak AO, Swiatkowska A, Clare S, Schejtman A, Santilli G, Arends MJ, Adams DJ.

J Pathol. 2018 Nov;246(3):300-310. doi: 10.1002/path.5140. Epub 2018 Sep 19.

PMID:
30062795
11.

Anti-CTLA-4 based therapy elicits humoral immunity to galectin-3 in patients with metastatic melanoma.

Wu X, Giobbie-Hurder A, Connolly EM, Li J, Liao X, Severgnini M, Zhou J, Rodig S, Hodi FS.

Oncoimmunology. 2018 Mar 13;7(7):e1440930. doi: 10.1080/2162402X.2018.1440930. eCollection 2018.

12.

Lactulose as a novel template for anticancer drug development targeting galectins.

Kishor C, Ross RL, Blanchard H.

Chem Biol Drug Des. 2018 Oct;92(4):1801-1808. doi: 10.1111/cbdd.13348. Epub 2018 Jul 1.

PMID:
29888844
13.

The Role of Galectins in Cervical Cancer Biology and Progression.

Wang L, Zhao Y, Wang Y, Wu X.

Biomed Res Int. 2018 May 8;2018:2175927. doi: 10.1155/2018/2175927. eCollection 2018. Review.

14.

Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3.

Fang T, Liu DD, Ning HM, Dan Liu, Sun JY, Huang XJ, Dong Y, Geng MY, Yun SF, Yan J, Huang RM.

Acta Pharmacol Sin. 2018 May 16. doi: 10.1038/s41401-018-0004-z. [Epub ahead of print]

PMID:
29769742
15.

Multiple coagulation factor deficiency protein 2 as a crucial component in metastasis of human oral cancer.

Fukamachi M, Kasamatsu A, Endo-Sakamoto Y, Fushimi K, Kasama H, Iyoda M, Minakawa Y, Shiiba M, Tanzawa H, Uzawa K.

Exp Cell Res. 2018 Jul 1;368(1):119-125. doi: 10.1016/j.yexcr.2018.04.021. Epub 2018 Apr 19.

PMID:
29679592
16.

Interstitial fibrosis in papillary thyroid microcarcinoma and its association with biological behavior.

Liu X, Zhang S, Gang Q, Shen S, Zhang J, Lun Y, Xu D, Duan Z, Xin S.

Oncol Lett. 2018 Apr;15(4):4937-4943. doi: 10.3892/ol.2018.7928. Epub 2018 Feb 2.

17.

β4-Integrin/PI3K Signaling Promotes Tumor Progression through the Galectin-3-N-Glycan Complex.

Kariya Y, Oyama M, Hashimoto Y, Gu J, Kariya Y.

Mol Cancer Res. 2018 Jun;16(6):1024-1034. doi: 10.1158/1541-7786.MCR-17-0365. Epub 2018 Mar 16.

PMID:
29549127
18.

The role of galectin-3 in the tumorigenesis and progression of pituitary tumors.

Diao B, Liu Y, Xu GZ, Zhang Y, Xie J, Gong J.

Oncol Lett. 2018 Apr;15(4):4919-4925. doi: 10.3892/ol.2018.7931. Epub 2018 Feb 2.

19.

Swallow root (Decalepis hamiltonii) pectic oligosaccharide (SRO1) induces cancer cell death via modulation of galectin-3 and survivin.

Mallikarjuna SE, Dharmesh SM.

Carbohydr Polym. 2018 Apr 15;186:402-410. doi: 10.1016/j.carbpol.2018.01.053. Epub 2018 Jan 31.

PMID:
29456003
20.

Do MCF7 cells cope with metformin treatment under energetic stress in low glucose conditions?

Dogan Turacli I, Umudum H, Pampal A, Candar T, Kavasoglu L, Sari Y.

Mol Biol Rep. 2018 Jun;45(3):195-201. doi: 10.1007/s11033-018-4152-5. Epub 2018 Feb 3.

PMID:
29397517

Supplemental Content

Loading ...
Support Center